ResearchMoz

Acute Ischemic Stroke Global Clinical Trials Review, Q1, 2011

Publisher Name » GlobalData
Published Date » 2011-01-30
No. Of Pages » 71

GlobalData's clinical trial report, “Acute Ischemic Stroke Global Clinical Trials Review, Q1, 2011 provides data on the Acute Ischemic Stroke clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Acute Ischemic Stroke. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status and trial success rate
  • Review of key discontinued trials (suspended, withdrawn and terminated)
  • Overview of the enrollment pattern by phase for the past decade
  • Number of clinical trials segmented by key drugs
  • Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
  • Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others
Reasons to buy

  • Understand the dynamics of a particular indication as a whole
  • Examine the performance of the trials in terms of their status, recruitment, success rates and others
  • Obtain discontinued trial information for trials across the globe
  • Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2

List of Tables 4
List of Figures 6
Introduction 7
Acute Ischemic Stroke 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Unaccomplished Trials of Acute Ischemic Stroke 20
Subjects Recruited Over a Period of Time 22
Prominent Sponsors 23
Top Companies Participating in Acute Ischemic Stroke Therapeutics Clinical Trials 25
Prominent Drug Comparison 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Mitsubishi Tanabe Pharma Corporation 28
Clinical Trial Overview of Mitsubishi Tanabe Pharma Corporation 28
H Lundbeck A/S 29
Clinical Trial Overview of H Lundbeck A/S 29
Concentric Medical, Inc. 30
Clinical Trial Overview of Concentric Medical, Inc. 30
AstraZeneca PLC 31
Clinical Trial Overview of AstraZeneca PLC 31
ImaRx Therapeutics, Inc. 32
Clinical Trial Overview of ImaRx Therapeutics, Inc. 32
PhotoThera, Inc. 33
Clinical Trial Overview of PhotoThera, Inc. 33
Neurobiological Technologies, Inc. 34
Clinical Trial Overview of Neurobiological Technologies, Inc. 34
Ono Pharmaceutical Co., Ltd. 35
Clinical Trial Overview of Ono Pharmaceutical Co., Ltd. 35
PAION AG 36
Clinical Trial Overview of PAION AG 36
Bayer AG 37
Clinical Trial Overview of Bayer AG 37
Talecris Biotherapeutics Holdings Corp 38
Clinical Trial Overview of Talecris Biotherapeutics Holdings Corp 38
Pfizer Inc. 39
Clinical Trial Overview of Pfizer Inc. 39
Orion Corporation 40
Clinical Trial Overview of Orion Corporation 40
Forest Laboratories, Inc. 41
Clinical Trial Overview of Forest Laboratories, Inc. 41
Astellas Pharma Inc. 42
Clinical Trial Overview of Astellas Pharma Inc. 42
Aldagen, Inc. 43
Clinical Trial Overview of Aldagen, Inc. 43
Nexstim Oy 44
Clinical Trial Overview of Nexstim Oy 44
Merck & Co., Inc. 45
Clinical Trial Overview of Merck & Co., Inc. 45
BrainsGate 46
Clinical Trial Overview of BrainsGate 46
Sanofi-Aventis 47
Clinical Trial Overview of Sanofi-Aventis 47
Clinical Trial Overview of Top Universities / Institutes / Hospitals 48
University of California, San Diego 48
Clinical Trial Overview of University of California, San Diego 48
Duke University 49
Clinical Trial Overview of Duke University 49
Assistance Publique - Hopitaux de Paris 50
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 50
FUDAN University 51
Clinical Trial Overview of FUDAN University 51
The University of Texas Health Science Center at Houston 52
Clinical Trial Overview of The University of Texas Health Science Center at Houston 52
Charite University 53
Clinical Trial Overview of Charite University 53
Henry Ford Health System 54
Clinical Trial Overview of Henry Ford Health System 54
University of Cincinnati 55
Clinical Trial Overview of University of Cincinnati 55
Sunnybrook Health Sciences Centre 56
Clinical Trial Overview of Sunnybrook Health Sciences Centre 56
University Hospital, Toulouse 57
Clinical Trial Overview of University Hospital, Toulouse 57
Xijing Hospital 58
Clinical Trial Overview of Xijing Hospital 58
Mount Sinai School of Medicine 59
Clinical Trial Overview of Mount Sinai School of Medicine 59
University of Heidelberg 60
Clinical Trial Overview of University of Heidelberg 60
Chinese Academy of Medical Sciences and Peking Union Medical College 61
Clinical Trial Overview of Chinese Academy of Medical Sciences and Peking Union Medical College 61
Hallym University Medical Center 62
Clinical Trial Overview of Hallym University Medical Center 62
Wolfson Medical Center 63
Clinical Trial Overview of Wolfson Medical Center 63
Taipei Medical University WanFang Hospital 64
Clinical Trial Overview of Taipei Medical University WanFang Hospital 64
Guangzhou Univeristy of Traditional Chinese Medicine 65
Clinical Trial Overview of Guangzhou Univeristy of Traditional Chinese Medicine 65
Hvidovre University Hospital 66
Clinical Trial Overview of Hvidovre University Hospital 66
New York University School of Medicine 67
Clinical Trial Overview of New York University School of Medicine 67

Appendix 68

Abbreviations 68
Definitions 68
Research Methodology 69
Secondary Research 70
About GlobalData 70
Contact Us 70
Disclaimer 70
Source 71

List of Tables


Acute Ischemic Stroke Therapeutics Market, Global, Clinical Trials by Zone, 2011* 8
Acute Ischemic Stroke Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 9
Acute Ischemic Stroke Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 10
Acute Ischemic Stroke Therapeutics Clinical Trials, Asia-Pacific , Top Five Countries, 2011* 11
Acute Ischemic Stroke Therapeutics Clinical Trials, Europe, Top Five Countries, 2011* 12
Acute Ischemic Stroke Therapeutics Clinical Trials, North America, Top Countries, 2011* 13
Acute Ischemic Stroke Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011* 14
Acute Ischemic Stroke Therapeutics Clinical Trials, Central and South America, Top Countries, 2011* 15
Acute Ischemic Stroke Therapeutics Clinical Trials, BRIC Countries, 2011* 16
Acute Ischemic Stroke Therapeutics Market, Global, Clinical Trials by Phase, 2011* 17
Acute Ischemic Stroke Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011* 18
Acute Ischemic Stroke Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 19
Acute Ischemic Stroke Therapeutics Market, Global, Suspended Clinical Trials, 2011* 20
Acute Ischemic Stroke Therapeutics Market, Global, Terminated Clinical Trials, 2011* 21
Acute Ischemic Stroke Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 22
Acute Ischemic Stroke Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 24
Acute Ischemic Stroke Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 26
Acute Ischemic Stroke Therapeutics Clinical Trials, Global, Clinical Trial by Prominent Drugs, 2011* 27
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Tanabe Pharma Corporation, 2011* 28
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by H Lundbeck A/S, 2011* 29
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Concentric Medical, Inc., 2011* 30
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2011* 31
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by ImaRx Therapeutics, Inc., 2011* 32
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by PhotoThera, Inc., 2011* 33
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurobiological Technologies, Inc., 2011* 34
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Ono Pharmaceutical Co., Ltd., 2011* 35
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by PAION AG, 2011* 36
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2011* 37
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Talecris Biotherapeutics Holdings Corp, 2011* 38
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2011* 39
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Orion Corporation, 2011* 40
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2011* 41
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2011* 42
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Aldagen, Inc., 2011* 43
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Nexstim Oy, 2011* 44
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2011* 45
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by BrainsGate, 2011* 46
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi-Aventis, 2011* 47
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2011* 48
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2011* 49
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2011* 50
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2011* 51
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at Houston, 2011* 52
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite University, 2011* 53
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Henry Ford Health System, 2011* 54
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cincinnati, 2011* 55
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Sunnybrook Health Sciences Centre, 2011* 56
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Toulouse, 2011* 57
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Xijing Hospital, 2011* 58
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai School of Medicine, 2011* 59
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2011* 60
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese Academy of Medical Sciences and Peking Union Medical College, 2011* 61
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Hallym University Medical Center, 2011* 62
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Wolfson Medical Center, 2011* 63
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Taipei Medical University WanFang Hospital, 2011* 64
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Guangzhou Univeristy of Traditional Chinese Medicine, 2011* 65
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Hvidovre University Hospital, 2011* 66
Acute Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2011* 67

List of Figures


Acute Ischemic Stroke Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 8
Acute Ischemic Stroke Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 9
Acute Ischemic Stroke Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 10
Acute Ischemic Stroke Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011* 11
Acute Ischemic Stroke Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011* 12
Acute Ischemic Stroke Therapeutics Clinical Trials, North America, Top Countries (%), 2011* 13
Acute Ischemic Stroke Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2011* 14
Acute Ischemic Stroke Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2011* 15
Acute Ischemic Stroke Therapeutics Clinical Trials, BRIC Countries (%), 2011* 16
Acute Ischemic Stroke Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 17
Acute Ischemic Stroke Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011* 18
Acute Ischemic Stroke Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 19
Acute Ischemic Stroke Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 22
Acute Ischemic Stroke Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 23
Acute Ischemic Stroke Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 25
Acute Ischemic Stroke Therapeutics Clinical Trials, Global, Clinical Trial by Prominent Drugs, 2011* 27
GlobalData Methodology 69

Upcoming Reports:

Merchant-Paid Rewards Market: Industry Analysis, Market Size, Share, Trends, Growth And Forecast, 2011 - 2018
By - Transparency Market Research
Debit card users are increasing in number as compared to credit card users. Use of debit card allows the consumers to save money for future use as they know how much money they have and how much money they have to spend. This trend leads to the growth of merchant paid reward programs. Credit cards do not give customers this privilege as they pay later for whatever they have purchased. Merchant-paid programs persuade customers to use their debit cards rather than credit cards or paper coupons. Merchant paid programs are gaining popularity in the market as it offers...
Biomarkers Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
A biomarker is a gene, molecule or characteristics, by which pathogenic processes, biological processes or pharmacologic response can be evaluated or measured. They are classified on the basis of their application in different medical processes. These biomarkers help effectively in clinical decision making and thus help in diagnosing the health of a patient. In the present scenario, biomarkers are extensively used in the treatment of diseases such as cancer. The worldwide market of biomarkers is increasing tremendously due to its popularity and wide use in different...
Silicon-on-Insulator (SOI) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Silicon-on-Insulators (SOI) are made up of a thin silicon uppermost layer and a thicker silicon lowermost layer with an insulating material like silicon dioxide forming the middle layer between these silicon layers. SOI are valued for their high performance characteristics, low energy wastage, low power usage, and higher speeds as opposed to regular silicon wafers. With such properties, SOI are in much demand for their use in mobile phones, notebooks, digitalized cameras, and in other such electronic devices. Initially, the American military had used SOI in the 1960s before it was...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...